Register
Long-Term Effect of Rifaximin with and without Lactulose in Minimal Hepatic Encephalopathy. |
Molecule Updates
eMediNexus Coverage from: 
Long-Term Effect of Rifaximin with and without Lactulose in Minimal Hepatic Encephalopathy.
eMediNexus,  03 December 2018
remove_red_eye 478 Views
#Gastroenterology #Internal Medicine

0 Read Comments                

The purpose of a new study published in Digestive Diseases was to characterize active bacterial assemblages in the duodenum and feces in patients with minimal hepatic encephalopathy (MHE) before, during, and after long-term therapy with rifaximin. In this study, the gut microbiota composition of 5 patients with liver cirrhosis and MHE, who had been treated either with rifaximin 550 mg bid alone continuously for a period of 3 months or combined with lactu

To continue reading this article
Or

Continue reading your article with a Emedinexus account..
Free Membership!